Isracann Biosciences Inc. (ISCNF)
- Previous Close
0.0001 - Open
0.0001 - Bid --
- Ask --
- Day's Range
0.0001 - 0.0001 - 52 Week Range
0.0001 - 0.0367 - Volume
23,333 - Avg. Volume
3,245 - Market Cap (intraday)
1.992M - Beta (5Y Monthly) 0.03
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
www.isracann.com--
Full Time Employees
May 31
Fiscal Year Ends
Sector
Related News
Performance Overview: ISCNF
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISCNF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISCNF
Valuation Measures
Market Cap
17.60k
Enterprise Value
-126.86k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.19
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
0.03
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-34.99%
Return on Equity (ttm)
-252.75%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.54M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
198.05k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-567.05k
Company Insights: ISCNF
ISCNF does not have Company Insights